September - 2026

top of page

Middle East CF Association Log

MECFA Blog

News & Articles

International CF Training Network and MECFA Diagnostics Program Expand to Pakistan in Partnership with Indus Hospital and Health Network

CFF-funded ICFTN training, MECFA MADI diagnostic donations, European CF registry participation, and Vertex free modulator access converge to bring comprehensive CF support to Pakistani patients for the first time. KARACHI / ISTANBUL / BOSTON — The Middle East Cystic Fibrosis Association (MECFA) and the Marmara University Cystic Fibrosis Center have completed a clinical assessment visit to the Indus Hospital and Health Network (IHHN) in Karachi, launching a structured CF capac

International CF Training Network and MECFA Diagnostics Program Expand to Pakistan in Partnership with Indus Hospital and Health Network

International CF Training Network and MECFA Diagnostics Program Expand to Pakistan in Partnership with Indus Hospital and Health Network

Featured Posts

Disease Duration, Flare-ups Affect Mental Health of Non-CF Bronchiectasis Patients, Study Finds

Disease Duration, Flare-ups Affect Mental Health of Non-CF Bronchiectasis Patients, Study Finds

Disease Duration, Flare-ups Affect Mental Health of Non-CF Bronchiectasis Patients, Study Finds

VERTEX’S CF BLOCKBUSTER TRIKAFTA EFFECTIVE IN KIDS 6 TO 11 YEARS OF AGE

VERTEX’S CF BLOCKBUSTER TRIKAFTA EFFECTIVE IN KIDS 6 TO 11 YEARS OF AGE

VERTEX’S CF BLOCKBUSTER TRIKAFTA EFFECTIVE IN KIDS 6 TO 11 YEARS OF AGE

A case for improved carrier screening

A case for improved carrier screening

A case for improved carrier screening

Vertex to Seek Expanded FDA Approval for Trikafta After Positive Child Safety Data

Vertex to Seek Expanded FDA Approval for Trikafta After Positive Child Safety Data

Vertex to Seek Expanded FDA Approval for Trikafta After Positive Child Safety Data

Vertex’s Kaftrio approved for use in Europe and made accessible on the NHS

Vertex’s Kaftrio approved for use in Europe and made accessible on the NHS

Vertex’s Kaftrio approved for use in Europe and made accessible on the NHS

Age May Affect Outcomes in Lung Transplant Recipients With Cystic Fibrosis

Age May Affect Outcomes in Lung Transplant Recipients With Cystic Fibrosis

Age May Affect Outcomes in Lung Transplant Recipients With Cystic Fibrosis

CFF Funding Will Further ContraFect’s Research Into Alternative for Antibiotics

CFF Funding Will Further ContraFect’s Research Into Alternative for Antibiotics

CFF Funding Will Further ContraFect’s Research Into Alternative for Antibiotics

The search for molecular glue in targeted disease control

The search for molecular glue in targeted disease control

The search for molecular glue in targeted disease control

Vest Therapy Lowers Risk of Hospitalization in Non-CF Bronchiectasis, Study Says

Vest Therapy Lowers Risk of Hospitalization in Non-CF Bronchiectasis, Study Says

Vest Therapy Lowers Risk of Hospitalization in Non-CF Bronchiectasis, Study Says

Harvard is working with Boston hospitals to test existing cystic fibrosis drug to help coronavirus p

Recent Posts

International CF Training Network and MECFA Diagnostics Program Expand to Pakistan in Partnership with Indus Hospital and Health Network

Two Stickers and a Phone Camera Matched the Lab Test for Cystic Fibrosis, at About a Dollar a Test

FDA Publishes New Product-Specific Guidances to Facilitate Generic Drug Development

Cystic fibrosis signs in newborns may not predict poorer long-term outcomes

'100M Healthy Lives' Initiative: 792K newborns screened for genetic diseases

Phase 2a trial testing mRNA therapy in cystic fibrosis fully enrolled

CFF funds cell-based strategy to help rebuild damaged CF airways

Approved CF med can also lessen airway inflammation, study finds

DNA sequencing may help revolutionize CF lung infection care: Study

Retransplanted Lungs Used in CF Quadruple Organ Transplant

Archive

Search By Tags

bottom of page